Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health Limited was originally incorporated in the name of Gaudium IVF and Women Health Private Limited as a Private Limited Company dated March 24 2015 with the RoC Delhi and Haryana. Subsequently the status of the Company was converted from a Private Limited into a Public Limited and the name was changed to Gaudium IVF and Women Health Limited and a fresh Certificate of Incorporation dated October 24 2024 was issued by the Central Processing Center.Company is engaged in IVF In vitro fertilization treatment in India and has grown into several states with Hub and spoke model over the years. Gaudium IVF is founded by the Promoter Dr. Manika Khanna a specialist with advanced training in gynecological endoscopic surgery from Kiel Germany and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited. The Company operates 30 locations which comprises of 7 hubs centers and 28 spokes company has entered into a strategic alliance with Spokes i.e Infertility Expert to achieve the mutual goal of spreading awareness about ART and IVF treatment. Their treatments include In Vitro Fertilization IVF Intracytoplasmic Sperm Injection ICSI Intrauterine Insemination IUI and ovulation induction all our treatment is carefully designed to address a variety of infertility challenges for both male and female.The Company began its journey by starting the business operations at Gaudium Hospital in 2019. Gaudium IVF and Gynae Solutions a proprietary firm of Dr. Manika Khanna was acquired by the Company in accordance with the main object clause pursuant to a preferential allotment dated March 29 2021. This acquisition was executed through the issuance of 940232 equity shares.The Company acquired 100 shares of Gaudium International Private Limited making it a wholly owned subsidiary of the Company on February 2 2023. The Company further acquired Gaudium Bawa Ludhiana Centre as a going concern via slump sale in 2023. In 2024 Company has started Srinagar Centre in Jammu Kashmir started Banglore Centre in Karnataka. The Company offer a complete specialized fertility and reproductive health services. The advance treatments include In Vitro Fertilization IVF Intracytoplasmic Sperm Injection ICSI Intrauterine Insemination IUI and ovulation induction all our treatment is carefully designed to address a variety of infertility challenges for both male and female. It also offers comprehensive gynecological care including PCOD/PCOS and endometriosis. Further highrisk pregnancy management is provided for women with complex fertility histories or health conditions. The wellness aspect includes fertility wellness programs offering nutritional counselling and psychological support to ensure holistic care for couples undergoing treatments.Apart from these the facilities provide a comprehensive range of male infertility treatments including advanced sperm retrieval techniques. For fertility preservation Company offer cryopreservation services for eggs freezing for future fertilization utilizing stateoftheart technology to ensure optimal success rates in future IVF cycles. Additionally the centers specialize in Frozen Embryo Transfers FET. They also offer laparoscopic and hysteroscopic surgeries for diagnosis and treatment of infertilityrelated conditions as well as genetic testing options including Preimplantation Genetic Testing PGT designed to enhance pregnancy outcomes and mitigate the risks of genetic disorders.The Company is planning an Initial Public Issue aggregating of upto 20886100 Equity Shares of face value of Rs 5/ each comprising a fresh issue of 18354400 equity shares and 2531700 equity shares through offer for sale..

Revenue: ₹24.51Cr as on December 2025 (Q3 FY26)
Net Profit: ₹3.63Cr as on December 2025 (Q3 FY26)
Listing date: 27 Feb, 2026
Chairperson Name: Manika Khanna